Mitomics: Mitomics Turns to Optimized Capital Markets for Crowdfunding Round

Mitomics Seeks $5 Million in Equity Crowdfunding on Optimize Capital Markets. Mitomics has positioned their company to be a leaders in the niche market of mitochondrial DNA (mtDNA) technology. They claim their unique structural and functional characteristic of mtDNA make it a highly sought after system for discovery in biomarking, early disease detection, monitoring, and risk... Read MoreThe post Mitomics Turns to Optimized Capital Markets for Crowdfunding Round appeared first on Crowdfund Insider.